GlassScriptPhysician profile
Isheeka Edwards
NPI 1134495930
$1,180.73
in general payments reported to CMS, 2019-2025
15 companies · $351 in 2025
The $351 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $115 · 2021: $13.71 · 2022: $199 · 2023: $19.47 · 2024: $255 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $285.65 | 2022-2024 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.59 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $125.67 | 2019-2025 | |
| Pfizer INC. | $123.88 | 2024-2025 | |
| Abiomed | $86.38 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $80.61 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $75.45 | 2019-2025 | Repatha |
| Heartflow, INC. | $36.64 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.60 | 2022-2025 | Lifevest |
| Chiesi USA, INC. | $34.53 | 2019 | |
| Philips North America LLC | $27.94 | 2025 | Dose Professional Services |
| Bridgebio Pharma, INC. | $27.49 | 2025 | Attruby |
| Amarin Pharma, INC. | $18.84 | 2019 | |
| Scpharmaceuticals INC. | $13.75 | 2025 | |
| Janssen Pharmaceuticals, INC | $13.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isheeka Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.